3 years of innovation never looked so sweet! Celebrating Exai’s 3rd anniversary today, one donut (and breakthrough) at a time! #lifeatexai

Exai celebrates diversity and wishes everyone a very happy Pride Month. #PrideMonth #earlydetection #lifeatexai #MRD

Proud to present our latest RNA- and AI-based #liquidbiopsy research at #ASCO24! #earlydetection #lifeatexai #MRD

The Exai team had a productive week at #AACR24! We were proud to showcase our #liquidbiopsy research in both early cancer detection and MRD.  #earlydetection #lifeatexai #MRD

Today, Exai presents new MRD data at #AACR24: Our onc-RNA- & AI-based #liquidbiopsy platform can accurately predict survival for patients with TNBC with residual disease, suggesting Exai can aid in tailoring adjuvant treatment for TNBC patients. #MRD #lifeatexai www.exai.bio/news/exai-bi...